Restriction Enzyme Market Exhibits a revenue CAGR of 5.7% and is to Hit USD 647.41 million by 2031


Newark, New Castle, USA, April 18, 2023 (GLOBE NEWSWIRE) — As per the report by Growth Plus Reports, the global Restriction Enzyme Market size is expected to reach US$ 647.41 million in 2031, at a CAGR of 5.7% during the forecast period, 2023-2031

The global restriction enzyme market size was estimated to grow during the forecast period with a significant revenue share. Restriction enzymes are used to identify and cut the DNA from a specific site, known as the restriction site, to manipulate the genes in recombinant DNA technologies. 

Recent Development in the Market: 


  • In September 2022, WhiteLab Genomics raised a platform for AI-driven genomic medicines to evolve genetic therapeutics. The business helps its clients quickly create target vectors and payloads and sell genomic-based medications. Financing and investments are therefore expected to create opportunities for advancement and innovation in genetic engineering, DNA mapping, and gene sequencing using restriction enzymes. 

Request a Sample Copy of the Research Report:

                                   Restriction Enzyme Market Scope

Report Attribute Details
Market size value in 2022 US$ 393.1 million
Revenue forecast in 2031 US$ 647.41 million
Growth Rate CAGR of 5.7% from 2023 to 2031
Base Year for Estimation 2022
Forecast Period 2023-2031
Historical Year 2021
Segments Covered Type, Application, End User, and Region.
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Key Takeaways: 

  • The increasing demand for personalized medicines and treatments drives the market revenue share. 
  • The growth of research activities and large R&D investments are boosting the demand for these tools. 
  • The growing demand for synthetic biology will likely accelerate market revenue during the forecast period. 

Market Drivers and Restraints: 

The increasing research activities in molecular biology for DNA sequencing, gene editing, and cloning drive the market revenue share. Furthermore, the demand for personalized medicines for genetic diseases, cancer, and other chronic disorders is expanding the demand for restriction enzymes in genetic and biotechnology research. 

The development of alternate technologies, such as CRISPR-Cas and TALENs, which are more precise and cost-effective, can retrain the market revenue growth of restriction enzymes. 

Market Segmentation: 

Segmentation By Type

Based on types, the global restriction enzyme market is segmented into type I, type II, type III, and others. The type I segment accounts for the largest market revenue share due to the specificity of the enzyme to cleave the DNA and identify difficult targets and longer sequences. 

Segmentation By Application

Based on applications, the global restriction enzyme market is segmented into genetic engineering, DNA mapping, gene sequencing, and others. The genetic engineering segment accounts for the largest revenue share in the global market. This large revenue share is attributed to the growing demand for genetically modified organisms and various gene expression analyses by cloning and genotyping.

Segmentation By End-User

Based on the end user, the global restriction enzyme is segmented into pharmaceutical & biotechnology companies, academic research institutes, and others. The pharmaceutical & biotechnology company accounts for the largest revenue share in the global market. This large revenue share is attributed to the rising investments in R&D studies and the production of novel therapeutics. 

Regional Growth Dynamics

Based on the region, the global restriction enzyme market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for the largest revenue share in the global market due to increasing R&D activities in drug designs, strong infrastructure, and emerging adoption of synthetic biology.

Request for Customization –

Competitive Landscape

A list of the market player operating in the global restriction enzyme market are: 

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • TransGen Biotech Co., Ltd.
  • Agilent Technologies Inc.
  • Genscript Biotech Corp.

Report Coverage 

The report analyzes the basic market fundamentals and dynamics, market strategies, key investment areas, regional growth analytics, revenue forecast, significant market players, and their collaborations. Additionally, the study provides a comprehensive discussion of the future of the restriction enzyme market globally. 

Table of Content

    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    1. Drivers
    2. Restraints
    3. Opportunities
    1. Type I
    2. Type II
    3. Type III
    4. Others
    1. Genetic Engineering
    2. DNA Mapping
    3. Gene Sequencing
    4. Others
    1. Pharmaceutical and Biotechnology Companies
    2. Academic Research Institutes
    3. Others


Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst:

Visit our report store at –

Browse Latest Healthcare Related Reports:

Pneumonia Testing Market by Type (Bacterial, Viral), Test Type (Blood Test, Sputum Test), Method (Immunodiagnostic, Molecular Diagnostics), Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence), End User (Hospitals, Diagnostic Centers) – Global Outlook and Forecast 2023-2031

Positive Expiratory Pressure Devices Market by Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices), Application (Atelectasis, Bronchiectasis), End User (Hospitals & Clinics, Ambulatory Surgical Centers) – Global Outlook & Forecast 2023-2031

Aortic Valve Replacement Devices Market by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Suture-less Valve), End User (Hospitals, Ambulatory Surgery Centers) – Global Outlook and Forecast 2023-2031

Antiplatelet Drugs Market by Drug Class (Irreversible Cyclooxygenase Inhibitors, Thromboxane inhibitors), Route of Administration (Oral, Parenteral), Indications (Acute Coronary Syndrome, Acute Ischemic Stroke) – Global Outlook and Forecast 2023-2031

Pharmaceutical Quality Management Systems Market by Deployment (On-cloud, On-premises), Solution Type (Audit Management, Document Management), End User (Pharmaceutical Companies, Contract Research Organizations) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.